Integration Between Metabolic Tumour Volume and Metabolic Heterogeneity Predicts Outcome of DLBCL Lymphoma Patients in the Sakk 38/07 Study Cohort
Hematological Oncology - United Kingdom
doi 10.1002/hon.47_2629
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley